Philip Morris (PM) Stock Forecast & Price Target

Philip Morris Intl is supported by resilient fundamentals, with strong combustible pricing, flat-to-positive volumes, and repeated revenue/EPS beats showing that legacy cash flows still fund growth. Its outlook is further strengthened by category leadership in IQOS and ZYN, where share gains and new variants are expanding the smoke-free runway, even as elevated U.S. ZYN investment pressures near-term OCI margins and EPS. Management’s renewed medium-term targets, roughly 6%-8% organic sales growth, 8%-10% organic operating profit growth, and 9%-11% EPS growth in 2026-2028, plus strong free cash flow and deleveraging toward 2.0x by the end of 2026, provide clear support for the bullish view.

Philip Morris Intl is facing a bearish setup as IQOS could lose share while rising competition in U.S. nicotine pouches slows revenue growth and pressures gross margin and earnings. Combustible volumes may decline faster than pricing can offset, leading to revenue declines and margin contraction across the core business. The outlook is further weakened by a potentially longer-than-expected IQOS PMTA process in the U.S. and unforeseen FDA compliance hurdles that could disrupt operations and weigh on the trading multiple.